GlassScriptPhysician profile
Amanda Chaffin
NPI 1013391838
$823.14
in general payments reported to CMS, 2019-2025
19 companies · $231 in 2025
The $231 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.71 · 2020: $56.03 · 2021: $142 · 2022: $116 · 2023: $65.82 · 2024: $123 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $101.09 | 2022-2025 | Doc Band |
| Glaxosmithkline, LLC. | $84.41 | 2019-2025 | Bexsero, Pediarix |
| Takeda Pharmaceuticals U.S.A., INC. | $68.67 | 2021-2022 | |
| Boston Scientific Corporation | $59.79 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Ironshore Pharmaceuticals INC. | $58.26 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $51.26 | 2024-2025 | |
| Kaleo, INC. | $47.72 | 2020-2022 | |
| Ultragenyx Pharmaceutical INC. | $47.16 | 2021 | |
| Collegium Pharmaceutical, INC. | $46.50 | 2025 | Jornay Pm |
| Tris Pharma INC | $41.93 | 2025 | Onyda Xr, Dyanavel Xr |
| Merck Sharp & Dohme LLC | $39.79 | 2021-2024 | Gardasil 9, Vaqta, Gardasil |
| Corium, LLC | $36.83 | 2023-2025 | Azstarys, Azstarys |
| Sanofi Pasteur INC. | $35.58 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $20.74 | 2024 | Flumist Quadrivalent |
| Avanos Medical | $18.11 | 2023 | Mic-Key |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $17.01 | 2019 | |
| Supernus Pharmaceuticals, INC. | $16.64 | 2022 | |
| Pfizer INC. | $16.06 | 2020 | |
| Neos Therapeutics, LP | $15.59 | 2024 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Chaffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.